AGTRAP and prostate cancer: Immunohistochemistry analysis highlighted the expression of AGTRAP in breast cancer, cervix cancer, colorectal cancer, endometrial cancer, glioma, head and neck cancer, liver cancer, lung cancer, lymphoma, melanoma, ovarian cancer, pancreatic cancer, prostate cancer, renal cancer, skin cancer, stomach cancer, testis cancer, thyroid cancer, and urothelial cancer (Figure 14).